Mackay Shields LLC’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-346,461
Closed -$7.83M 903
2021
Q1
$7.83M Sell
346,461
-392,687
-53% -$8.87M 0.06% 348
2020
Q4
$14.8M Buy
739,148
+66,459
+10% +$1.39M 0.1% 225
2020
Q3
$16.4M Sell
672,689
-95,627
-12% -$2.23M 0.11% 191
2020
Q2
$18.2M Buy
768,316
+115,376
+18% +$2.67M 0.15% 162
2020
Q1
$11.2M Buy
652,940
+417,596
+177% +$7.64M 0.1% 227
2019
Q4
$4.15M Buy
235,344
+23,328
+11% +$395K 0.03% 540
2019
Q3
$3.75M Buy
+212,016
New +$4.29M 0.02% 628
2019
Q2
Sell
-79,938
Closed -$1.9M 1433
2019
Q1
$1.9M Buy
+79,938
New +$1.82M 0.01% 719

Other funds holding EXEL

Mackay Shields LLC's EXEL Position: Q2 2021 in Review

Mackay Shields LLC sold out of Exelixis (EXEL) in Q2 2021, closing a stake of 346,461 shares — an estimated $7.83M sold.

Mackay Shields LLC first reported a position in EXEL in Q1 2019 and held it in 8 quarters. The position peaked at $18.2M in Q2 2020. 344 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

  • Mackay Shields LLC reported no remaining Exelixis position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 346,461 Exelixis shares in Q2 2021, an estimated $7.83M.
  • Mackay Shields LLC first reported a position in Exelixis in Q1 2019 and held it in 8 quarters.
  • Mackay Shields LLC's Exelixis position peaked at $18.2M in Q2 2020.
  • 344 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.